Impact Assessments for Supplier Change Notices
Watch the Course Now
Watch the Course Now
About the Course
Supplier-driven changes to materials, manufacturing processes, or production locations can directly affect product quality, manufacturing performance, and regulatory obligations within pharmaceutical and medical device operations. Regulatory agencies expect manufacturers to maintain effective oversight of suppliers and demonstrate that changes introduced within the supply chain are appropriately assessed before implementation. Weak supplier communication practices or inadequate impact evaluations can create inspection concerns, product variability, and operational disruption.
This course addresses the practical assessment of supplier change notices, including the role of supplier agreements, continuing guarantee statements, and structured review procedures. Attention is given to triage methods, team-based evaluations, and distinguishing low or no impact changes from those requiring full assessment activities. The course also discusses determining acceptable changes, applying risk-based levels of work, and responding appropriately when proposed supplier changes cannot be accepted.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


